TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01386411 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03303521 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00138060 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01450280 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05777707 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01212874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00378690 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01624064 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01038856 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT00281866 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00281125 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02905019 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT03635125 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01301573 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00185705 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00185705 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01026948 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02811289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00360360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00849459 — Safety Biomarker (SAF): Interleukin 12
Study NCT02093936 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03413358 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01448252 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT01622101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02028598 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03878537 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02632708 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02632708 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT01709032 — Predictive Biomarker (PRD): Liver iron
Study NCT03492177 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04356469 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00075569 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04611841 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03681483 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03370926 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01557972 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02923765 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02923765 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02923765 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02923765 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02781467 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01191684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01191684 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00002535 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT01388530 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study NCT03024983 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04405726 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00516750 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03811223 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04537949 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03382600 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT03382600 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03382600 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03382600 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00119379 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01902589 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03781986 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT03781986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01187901 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT01187901 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01187901 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03945292 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03941574 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03734159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04333173 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT04333173 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02519413 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03262701 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03903796 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03759522 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01208363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04426006 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03859388 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00003384 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02924038 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study NCT02924038 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04063358 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04063358 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03958630 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT00494169 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study NCT04006171 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04006171 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT03339856 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03418896 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03418896 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03656393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01398501 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02585791 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT01056965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01056965 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT04238702 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04238702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00545610 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03537560 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT01737697 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01105858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02993198 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02675491 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00914225 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02027610 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study NCT06609486 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00054496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00054496 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01950741 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00001475 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00001475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06771635 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00241007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02810262 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02810262 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02810262 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04070014 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01150955 — Predictive Biomarker (PRD): STAT5A mRNA
Genes: STAT5A; STAT5
Study NCT00268593 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00268593 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02584244 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT02073526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04424147 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT03990077 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02326844 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02027233 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03662126 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT00606307 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01999985 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01999985 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02243631 — Predictive Biomarker (PRD): ANK1 mRNA
Genes: ANK1; ANK
Study NCT01265030 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT01704079 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02843464 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02843464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02843464 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02843464 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT05741970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05741970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03630562 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04934774 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT02537951 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT02562235 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03198793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02512588 — Predictive Biomarker (PRD): BTD mRNA
Genes: BTD
Study NCT00486837 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04659421 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04659421 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00252811 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00207857 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00291369 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03417128 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02391090 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03804359 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study NCT01971580 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06105424 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03223272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04464798 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04015843 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02037815 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02090504 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT02580773 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03049228 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03049228 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study NCT03042988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01252771 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study NCT03316612 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04626596 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT00533819 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01153217 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00338091 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03529786 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT02048150 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04262141 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT04262141 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04262141 — Surrogate Endpoint (SUR): Hematologic response
Study NCT02728128 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT02954575 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06027775 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06027775 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03523065 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT02343575 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00007137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00526318 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT01358630 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04055493 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04055493 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03250689 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT03011684 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00549822 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00598481 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT00598481 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04008030 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00115726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01761786 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01274130 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study NCT01529190 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00029627 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01012973 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01012973 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02379247 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00231894 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02520518 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02520518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03206866 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study NCT00513461 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03570996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00570375 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00320879 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00320879 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT00375583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03139019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02869425 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT03855332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04734184 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00053391 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01653847 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study NCT02947685 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02947685 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02947685 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04606433 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01173315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02531789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02531789 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03090932 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03090932 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00670735 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT05008042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03207191 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT02147704 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04153006 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT03964233 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05128292 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT01672450 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00319735 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00319735 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04368507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04396626 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04396626 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04396626 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01932008 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02908906 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00657423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02993861 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02391025 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT02187549 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04585815 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00059748 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT00059748 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT03944980 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03799718 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00931099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01520623 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02999893 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00516880 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT02627209 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03923179 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02393157 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01220076 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01220076 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03941730 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02464709 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT01696097 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04329429 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04204161 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04204161 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00816660 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04192591 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT01300793 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00480350 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01715233 — Predictive Biomarker (PRD): CHFR mRNA
Genes: CHFR; RNF196
Study NCT04121676 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT01441128 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01441128 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03649269 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT03025633 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03598556 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00747383 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00263198 — Predictive Biomarker (PRD): Hormone receptor